Lund University Bioscience

What Lund University Bioscience does

Lund University Bioscience (LU Bio) is a private holding company partially owned by Lund University, founded in 2007 and headquartered in Lund, Sweden. As a university-affiliated holding vehicle, its implied role is to hold and manage equity interests in bioscience-related ventures, spinouts, and joint ventures emerging from the Lund University research ecosystem, including the adjacent Medicon Village and Science Village clusters. No specific portfolio companies, subsidiaries, products, services, customers, or revenue-generating activities are disclosed in the aggregated source material, so the company's operating scope cannot be characterized in detail beyond its holding-company function.

The input aggregates data across multiple source blocks, but the substantive material returned for the company's listed website (lubio.se) is content for a Norwegian consumer blog covering pin design, railings (rekkverk), and moving services in Bærum — content entirely unrelated to Lund University Bioscience. One source block explicitly notes the mismatch. As a result, product-level, customer-level, technology, and financial detail cannot be extracted from the input, and any specific claim about LU Bio's portfolio or operating activity would be unsupported by the supplied data.

The firmographic profile — private, partially owned by a major Swedish research university, 18 years in operation, domiciled in a recognized Nordic life-science cluster — is consistent with a long-standing strategic holding structure rather than an operating commercial entity. The absence of disclosed headcount, revenue, funding, leadership, or strategic actions in the source material represents a material data gap that constrains deeper analytical inference.

Name

Lund University Bioscience

Website

https://lubio.se

Company type

Private

Founded year

2007

Short description

Lund University Bioscience (LU Bio) is a private holding company partially owned by Lund University, founded in 2007 and based in Lund, Sweden, that holds equity interests in bioscience ventures emerging from the university's research ecosystem.

Ownership category

akta.pro rank

Product category

Biotechnology Holding Company

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Research and Development in the Physical, Engineering, and Life Sciences (54171)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Biomedical Sciences & Medical Research Institutes (University-Based) (EDAHAGAI)

Keywords

• Bioscience holding company
• Life sciences investment
• Biotech commercialization
• University spinouts
• Research portfolio management

Headquarters

HQ city

Lund

HQ country

Sweden

HQ region

Europe

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Others

Core offering

Lund University Bioscience (LU Bio) is a holding company partially owned by Lund University that manages and commercializes bioscience-related businesses and research assets originating from the university. Its core activity is stewarding a portfolio of life sciences ventures rather than selling a discrete consumer or enterprise product directly.

Differentiator

Problem solved

Functional benefit

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Direct peers

• Karolinska Development: Sweden-listed investment company that commercializes research from Karolinska Institutet. Direct comparable: university-affiliated Nordic bioscience holding/investment vehicle.
• Apollo Therapeutics: UK venture created with AstraZeneca, Ipsen, and three universities (incl. Cambridge/Imperial) to translate academic biomedical research into therapies. Comparable academic-to-commercial pipeline vehicle.
• Cambridge Innovation Capital: Cambridge University-linked growth investor in deep-tech and life sciences spinouts. Same university-commercialization holding model applied to UK bioscience.
• Oxford Science Enterprises (formerly OSI): Oxford University-affiliated investment company that builds and funds companies from university science. Closest structural analog outside the Nordics.

Emerging players

• BioInnovation Institute (BII): Danish non-profit venture builder within the Novo Nordisk Foundation that funds and incubates Nordic life-science start-ups. Regional peer in the Nordic bioscience commercialization space.
• Sunstone Capital: Danish/European early-stage life sciences venture firm that invests in biotech spinouts across the Nordics. Comparable as a regional bioscience venture investor with university-origin deal flow.
• Parkwalk Advisors: UK fund manager focused on UK university spinouts across life sciences and deep tech. Overlaps on university-derived bioscience deal flow and portfolio construction.
• Sciety: Sweden- and UK-based private investor platform syndicating Nordic/UK life sciences and tech spinout rounds. Comparable as a Nordic gateway to university-derived biotech investments.

Broad incumbents

• Imperial College Innovations / Imperial College Health Partners: Imperial College's technology transfer and health partnership arms that commercialize bioscience research. Broader incumbent in the same university-to-market model.
• M Ventures (Merck KGaA venture arm): Strategic corporate venture arm that invests in biotech/healthcare including university spinouts. Provides a benchmark for how strategic capital engages with academic bioscience pipelines.

Market position

Strengths3 records

Weaknesses3 records

Competitive moat2 records

Key risks4 records

Key highlights4 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments2 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Lund University Bioscience